PortfoliosLab logoPortfoliosLab logo
ISIN
CA74880P1045
IPO Date
May 27, 2021

Highlights

Market Cap
$159.17M
Enterprise Value
$299.43M
EPS (TTM)
-$0.25
Total Revenue (TTM)
$286.56M
Gross Profit (TTM)
$242.06M
EBITDA (TTM)
$46.35M
Year Range
$1.72 - $3.65
Target Price
$3.65
ROA (TTM)
-5.30%
ROE (TTM)
-10.65%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Quipt Home Medical Corp

Performance

QIPT Performance Chart


Loading charts...

S&P 500 Index

Returns By Period


Quipt Home Medical Corp

1D
1M
YTD
6M
1Y
3Y*
5Y*
10Y*

Benchmark (S&P 500 Index)

1D
0.13%
1M
5.68%
YTD
11.16%
6M
11.10%
1Y
27.46%
3Y*
21.12%
5Y*
12.66%
10Y*
13.75%
*Multi-year figures are annualized to reflect compound growth (CAGR)

QIPT Monthly Returns History


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20261.13%1.68%0.55%3.40%
20255.90%-18.27%-11.74%-7.73%-16.74%-0.00%23.46%19.00%-0.76%-6.13%-0.41%44.67%15.74%
2024-7.66%-8.72%1.86%-17.62%-6.67%-4.17%19.88%-25.91%2.10%-10.27%2.29%13.81%-40.08%
202323.14%8.28%11.62%-14.55%-18.20%8.98%-0.56%11.30%-13.87%-7.07%-0.63%8.30%8.07%
2022-6.24%-12.55%-4.57%2.51%5.56%-2.74%16.02%-9.51%-14.02%3.84%3.23%5.37%-16.04%
2021-3.89%-9.28%-12.26%18.73%-3.37%-12.04%12.07%-9.81%-21.97%

Benchmark Metrics

Quipt Home Medical Corp has an annualized alpha of -4.59%, beta of 0.55, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since May 28, 2021.

  • This stock participated in 70.40% of S&P 500 Index downside but only -8.02% of its upside - more exposed to losses than it benefited from rallies.
  • Beta of 0.55 may look defensive, but with R2 of 0.03 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-4.59%
Beta
0.55
0.03
Upside Capture
-8.02%
Downside Capture
70.40%

Return for Risk

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Quipt Home Medical Corp (QIPT) and compare them to S&P 500 Index.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Dividends

Dividend History


Quipt Home Medical Corp doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Quipt Home Medical Corp. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Quipt Home Medical Corp was 80.68%, occurring on May 19, 2025. The portfolio has not yet recovered.


Related event

Drawdown

Fall

Recovery

Underwater

2025 selloff2025
-80.68%May 2025
2y 1mo
3y 2moApr 2023 - now
Bear market2022
-45.34%Oct 2022
1y 4mo5mo 21d
1y 10moMay 2021 - Apr 2023

Drawdown Indicators


QIPTBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-56.78%

Max Drawdown (1Y)

Largest decline over 1 year

-9.10%

Max Drawdown (3Y)

Largest decline over 3 years

-18.90%

Max Drawdown (5Y)

Largest decline over 5 years

-25.43%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

0.00%

Average Drawdown

Average peak-to-trough decline

-10.72%

Ulcer Index

Depth and duration of drawdowns from previous peaks

1.97%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Quipt Home Medical Corp over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Quipt Home Medical Corp is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for QIPT relative to other companies in the Medical Devices industry. Currently, QIPT has a P/S ratio of 0.6. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for QIPT in comparison with other companies in the Medical Devices industry. Currently, QIPT has a P/B value of 1.6. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with QIPT

Add Quipt Home Medical Corp to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with QIPT